Janos Nadas

发表

Accessibility of N-acyl-D-mannosamines to N-acetyl-D-neuraminic acid aldolase.

S. Wen, Zhongwu Guo, Yanbin Pan, 2004, Carbohydrate research.

Anthracyclines as effective anticancer drugs

Duxin Sun, Janos Nadas, 2006, Expert opinion on drug discovery.

Shapes of sulfur, oxygen, and nitrogen mustards.

B. Hay, Janos Nadas, Xiaohua Zhang, 2011, The journal of physical chemistry. A.

Targeting PRPK Function Blocks Colon Cancer Metastasis

Weiya Ma, A. Bode, Z. Dong, 2018, Molecular Cancer Therapeutics.

Computer-aided design of host molecules for recognition of organic guests

B. Hay, Chuandong Jia, Janos Nadas, 2014 .

The conductance of bile salt-lecithin-water mixtures

D. F. Evans, John Meurig Thomas, Janos Nadas, 1972 .

The Roles of 3′ and 4′ Hydroxy Groups in α‐Galactosylceramide Stimulation of Invariant Natural Killer T Cells

P. Wang, M. Kronenberg, Wenpeng Zhang, 2009, ChemMedChem.

Design criteria for polyazine extractants to separate An(III) from Ln(III.).

B. Hay, Janos Nadas, L. Watson, 2013, Inorganic chemistry.

Alkyl chlorides as hydrogen bond acceptors

B. Hay, S. Vuković, Janos Nadas, 2012 .

Transport processes in hydrogen-bonding solvents. V. Conductance of tetraalkylammonium salts in 2-propanol

Janos Nadas, S. M. A. Matesich, D. F. Evans, 1970 .

Conductance of electrolytes in acetone and in 1-propanol-acetone mixtures at 25.deg.

John Meurig Thomas, Janos Nadas, S. M. A. Matesich, 1971 .

Eriodictyol Inhibits RSK2-ATF1 Signaling and Suppresses EGF-induced Neoplastic Cell Transformation*

Yong-Yeon Cho, Ji-shuai Zhang, A. Bode, 2010, The Journal of Biological Chemistry.

Modifying the sugar moieties of daunorubicin overcomes P-gp-mediated multidrug resistance.

Jie Shen, Duxin Sun, Yan-qiang Zhong, 2007, Molecular pharmaceutics.

Introduction of aromatic group on 4'-OH of α-GalCer manipulated NKT cell cytokine production.

P. Wang, Wenpeng Zhang, C. Xia, 2011, Bioorganic & medicinal chemistry.

Computational Structure Activity Relationship Studies on the CD1d/Glycolipid/TCR Complex Using AMBER and AUTODOCK

Peng George Wang, Janos Nadas, Chenglong Li, 2009, J. Chem. Inf. Model..

Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analogues.

P. Wang, Wenpeng Zhang, Dapeng Zhou, 2007, The Journal of organic chemistry.

Targeting PRPK and TOPK for skin cancer prevention and therapy

Yong-Yeon Cho, A. Bode, Z. Dong, 2018, Oncogene.

Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A₄hydrolase.

Yong-Yeon Cho, A. Bode, Z. Dong, 2010, Cancer research.

ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4

Yong-Yeon Cho, A. Bode, Z. Dong, 2012, Nature Structural &Molecular Biology.

15-Deoxy-Δ12,14-prostaglandin J2 stabilizes hypoxia inducible factor-1α through induction of heme oxygenase-1 and direct modification ofprolyl-4-hydroxylase 2

Z. Dong, Do-Hee Kim, Y. Surh, 2016, Free radical research.

(3-Chloroacetyl)-indole, a Novel Allosteric AKT Inhibitor, Suppresses Colon Cancer Growth In Vitro and In Vivo

Zigang Dong, Dong Joon Kim, Yan Li, 2011, Cancer Prevention Research.

Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B.

Weiya Ma, A. Bode, Z. Dong, 2017, Carcinogenesis.

Prediction of Molecular Targets of Cancer Preventing Flavonoid Compounds Using Computational Methods

Zigang Dong, Ronald A. Lubet, Ann M. Bode, 2012, PloS one.

4-Aryl-1,3,2-oxathiazolylium-5-olates as pH-controlled NO-donors: the next generation of S-nitrosothiols.

J. Zweier, P. Wang, F. Villamena, 2007, Journal of the American Chemical Society.

Transpot properties in hydrogen bonding solvents. VI. Conductance of electrolytes in 2,2,2-trifluoroethanol

Janos Nadas, S. M. A. Matesich, D. F. Evans, 1971 .

Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.

G. Szakács, P. Wang, Duxin Sun, 2006, Journal of Medicinal Chemistry.

Anthracyclines as effective anticancer drugs

Duxin Sun, Janos Nadas, 2006, Expert opinion on drug discovery.

Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B.

Weiya Ma, A. Bode, M. Kim, 2017, Carcinogenesis.